(Q47325422)

14 January 2018

title

How safe is the use of herbal weight-loss products sold over the internet? (English)

1 reference

14 January 2018

author name string

B Ozdemir

1

1 reference

14 January 2018

I Sahin

2

1 reference

14 January 2018

H Kapucu

3

1 reference

14 January 2018

O Celbis

4

1 reference

14 January 2018

Y Karakoc

5

1 reference

14 January 2018

S Erdogan

6

1 reference

14 January 2018

Y Onal

7

1 reference

14 January 2018

publication date

21 February 2012

1 reference

14 January 2018

Human & Experimental Toxicology

published in

1 reference

14 January 2018

volume

32

1 reference

14 January 2018

issue

1

1 reference

14 January 2018

page(s)

101-106

1 reference

14 January 2018

Presence of synthetic pharmaceuticals as adulterants in slimming phytotherapeutic formulations and their analytical determination

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Psychosis associated with usage of herbal slimming products adulterated with sibutramine: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Anorectic sibutramine detected in a Chinese herbal drug for weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Application of LC-ESI-MS-MS for detection of synthetic adulterants in herbal remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

A review of the potential forensic significance of traditional herbal medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Novel strategy for the use of leptin for obesity therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Rise and fall of anti-obesity drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

A benefit-risk assessment of sibutramine in the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Safety of drug therapies used for weight loss and treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Use and abuse of appetite-suppressant drugs in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Temazepam at high altitude reduces periodic breathing without impairing next-day performance: a randomized cross-over double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

A pilot study of chromium picolinate for weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

Impact of chromium histidinate on high fat diet induced obesity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

An examination of the association of selected toxic metals with total and central obesity indices: NHANES 99-02

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0960327112436407

21 January 2018

Identifiers

DOI

10.1177/0960327112436407

1 reference

14 January 2018

PubMed ID

22354083

1 reference

14 January 2018